X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER CYTOPATHOLOGY

期刊標題檢索 CANCER CYTOPATH 最新評論: Have you voted? Planning to give it a try? (2022-11-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER CYTOPATHOLOGY]您好,您是該頁面的第 25212 位訪客。

期刊簡介
期刊名稱CANCER CYTOPATHOLOGY CANCER CYTOPATHOLOGY
LetPub Score
7.4
50 ratings
Rate

Reputation
8.7

Influence
6.1

Speed
8.8

期刊簡稱CANCER CYTOPATHOL
ISSN1934-662X
E-ISSN1934-6638
h-index45
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.000.9911.183
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q196 / 404
Category: Medicine
Subcategory: Cancer Research
Q284 / 230

自引率 (2023-2024)15.40%自引率趨勢
掲載範囲
Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1934-6638
在線稿件提交https://mc.manuscriptcentral.com/cancercyto
開放訪問No
出版商Wiley-Blackwell
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年0
每年文章數66每年文章數趨勢
黃金OA百分比18.39%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3175/322
PATHOLOGYSCIEQ235/88
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1934-662X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【CANCER CYTOPATHOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Annual Review of Pathology-Mechanisms of DiseaseH-index: 105

    CiteScore: 62.60
    ENDOCRINE PATHOLOGYH-index: 42

    CiteScore: 12.30
    ACTA NEUROPATHOLOGICAH-index: 146

    CiteScore: 23.70
    Seminars in ImmunopathologyH-index: 85

    CiteScore: 19.80
    MODERN PATHOLOGYH-index: 139

    CiteScore: 14.30
    BRAIN PATHOLOGYH-index: 124

    CiteScore: 13.20
    JOURNAL OF PATHOLOGYH-index: 168

    CiteScore: 14.10
    ADVANCES IN ANATOMIC PATHOLOGYH-index: 69

    CiteScore: 10.30
    LABORATORY INVESTIGATIONH-index: 140

    CiteScore: 8.30
    AMERICAN JOURNAL OF PATHOLOGYH-index: 258

    CiteScore: 11.40
    學科內最受檢索的期刊 頁面查看次數
    Molecular Medicine Reports319936
    DISEASE MARKERS95475
    PATHOLOGY RESEARCH AND PRACTICE68897
    LABORATORY INVESTIGATION67709
    JOURNAL OF PATHOLOGY65836
    AMERICAN JOURNAL OF PATHOLOGY61287
    Diagnostic Pathology44447
    ACTA NEUROPATHOLOGICA44273
    PATHOLOGY & ONCOLOGY RESEARCH43801
    MODERN PATHOLOGY41817
  •  

    CANCER CYTOPATHOLOGY CANCER CYTOPATHOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CANCER CYTOPATHOLOGY] 的評論撰寫評論
作者: 白夏少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-17 16:13:03 評論於
Have you voted? Planning to give it a try?
(0) 讚! | 白夏少爷

作者: 东风从青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-14 23:37:35 評論於
Are you accepting articles on research into basic class mechanism functionality?
(0) 讚! | 东风从青

作者: 东风从青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-14 22:53:59 評論於
Are you accepting articles on the study of basic mechanisms of class acceptance?
(0) 讚! | 东风从青

作者: 东风从青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-13 16:45:49 評論於
Are there any recent recipients? Is it good? Please share your experience, grateful heart!
(0) 讚! | 东风从青

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:26:24 評論於
Thank you to the editors and reviewers; revisions take time, but experiments require time; please confirm the time needed
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:09:00 評論於
Subject: Submission column, article title, pen name for publication. Content: The entire content of the article.

Author information is at the end of the text. Author information includes: your actual contact address, zip code, name, email address, landline phone, mobile phone, QQ number (specify QQ name), and any other contact information you feel is necessary to provide (such as a brief introduction
(0) 讚! | 维尔娜菲茨杰拉德

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 14:41:08 評論於
What are some things to keep in mind when sending a letter to a journal?
(0) 讚! | 魂魄彦露

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 12:39:37 評論於
How to write a letter requesting an extension?
(0) 讚! | 陶宜三岁啦

作者: 无冬嘉歆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-07-21 08:03:47 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Emphasized research direction: Oncology
Metabolic experience sharing: After submitting the review, I received a rejection letter just 3 hours later, because they felt that the content of the submission did not quite align with their audience. They recommended submitting to another OA journal from the same publisher with a fee of 3.49. I agreed, but I am unsure of what will happen next. I will provide an update if it gets accepted
(0) 讚! | 无冬嘉歆

作者: 千花婉淑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-05 17:15:07 評論於
This magazine has such high circulation, why was it canceled?
(0) 讚! | 千花婉淑

作者: Barbee


領域: 医学
審稿時間: 4.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-21 17:00:51 評論於
Overall, Cancer Cytopathology is a very good journal. I wish that the review period was a little faster, and I hope that more articles are submitted so that it starts publishing monthly.

(0) 讚! | Barbee

作者: Marshall Arnold


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-20 20:35:11 評論於
Overall, it is a very good journal. I just hope the review process can be faster, and it would be great if it could become a monthly publication
(0) 讚! | Marshall Arnold

作者: 云居吉敏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-15 19:47:06 評論於
I'd like to ask, is nobody submitting to this magazine? Could you please provide some feedback? I'm thinking of submitting, but it seems like there are few submissions from China
(0) 讚! | 云居吉敏

作者: Jonas Franklin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-31 17:33:25 評論於
Submission rejection is really quick. I regret to inform you that the manuscript was not deemed to be within the top 20% of submitted manuscripts, and has not been accepted for publication in Cancer Cytopathology
(0) 讚! | Jonas Franklin

作者: 水月语芹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-11-05 15:52:56 評論於
How much is the advertising fee?
(0) 讚! | 水月语芹

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-05-01 13:49:59 評論於
It seems not, it should be a subsidiary publication
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-09-25 23:30:09 評論於
The submission is on the neuropathology of cerebrospinal fluid cells. The initial review is slow, taking about 3-4 months. After revision, there are 3 reviewers, the first 2 did not raise any issues. The third reviewer's comments are very strict, suggesting additional research that cannot be completed in a short period of time. The revision took 3 months (with a 1.5-month extension), followed by nearly 2 months for another review, and ultimately, the submission was rejected. There are many minor issues with the language of the article and the clarity of the images, but these are problems that can be resolved. It is difficult to accept that after about 8 months of review, the submission is rejected after one major revision. Subsequently, the score for this journal dropped drastically this year
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-03 22:46:14 評論於
Are Cancer and Cancer Cytopathology the same journal?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-05-15 23:20:20 評論於
What does "ON COPYEDIT" mean and what status should it be in?
(0) 讚! | 凌霄高洁

作者: 凤凰院俏丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-20 12:56:01 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0
Sharing experience: It's really refreshing. Rejected in three days is better than lingering rejection. No reasons given. It's a good journal, saves time
(0) 讚! | 凤凰院俏丽

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-06-23 18:15:24 評論於
Rejected in just 3 days, it feels really difficult
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-01-06 19:20:59 評論於
The journal name here is wrong, it should be abbreviated as CANCER-AM CANCER SOC, not cancer cytopathologyJ abbreviation, they are not the same journal at all. Change it quickly!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-03-10 10:21:56 評論於
Review Speed: 2.0
Experience Sharing: A good magazine, but not very popular domestically
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-02-08 22:10:18 評論於
The review process takes approximately 4-6 weeks for the first round, not 2-3 weeks
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-01-26 10:29:24 評論於
Rejected in three days. Editing is very good, at least it can save time
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CANCER CYTOPATHOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*